Glaucoma is a heterogeneous group of disorders usually associated with elevated
intraocular pressure (IOP), leading to optic nerve damage, retinal ganglion cell death and …

Barriers to effective medical therapy are numerous and include difficulties with effective and
sustained control of intraocular pressure (IOP) and adherence to prescribed anti‐glaucoma …

Reasons for performing study: Only few drugs with limited efficacy are available for topical
treatment of equine glaucoma. Objective: To evaluate the effect of topical administration of …

Objective To compare the reduction in intraocular pressure (IOP) by topical 2% dorzolamide
to oral methazolamide (5 mg/kg) in dogs, and determine if the combination of both drugs …

A drug may be administered by multiple routes to treat ocular (ie, adnexal, ocular surface,
intraocular, or orbital) disease. These routes are shown in Figure 3-1 and include the …

Canine glaucoma encompasses a diverse group of diseases associated with an increase in
intraocular pressure that results in retinal ganglion cell death and eventual blindness. Dogs …

IN A PERFECT WORLD, THE EFFICACY OF THERAPEUTIC agents for glaucoma would be
determined through large, well-planned, randomized controlled trials (RCTs), placebo …

OBJECTIVES To determine the effect of 1% brinzolamide, 2% dorzolamide hydrochloride or
combination 2% dorzolamide hydrochloride/0· 5% timolol to delay the elevation of the …

Glaucoma is a major cause of irreversible blindness in the world. The prevalence of
glaucomatous loss in vision will continue to grow as our populations age. Ocular …

Glaucoma is a heterogeneous group of progressive disorders characterized by retinal
ganglion cell (RGC) apoptosis and a specific optic neuropathy (glaucomatous optic …